Literature DB >> 22276743

Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis.

Wei Meng1, Ling Jiang, Lin Lu, Haiyan Hu, Hailang Yu, Dapeng Ding, Kun Xiao, Wenling Zheng, Hongbo Guo, Wenli Ma.   

Abstract

The oncogene, microRNA-155, is significantly elevated in GBM (glioblastoma multiforme), regulating multiple genes associated with cancer cell proliferation, apoptosis and invasiveness. Thus, miR-155 can theoretically become a target for enhancement of the chemotherapy in cancer. Down-regulating miR-155 to enhance the effect of taxol has not been studied in human GBM. Human GBM U251 cells were treated with taxol and the miR-155 inhibitor alone or in combination. IC50 values were dramatically decreased in cells treated with miR-155 inhibitor combined with taxol, to a greater extent than those treated with taxol alone. Furthermore, the miR-155 inhibitor significantly enhanced apoptosis in U251 cells. The data suggest that miR-155 blockage increased the chemosensitivity to taxol in GBM cells, making combined treatment an effective therapeutic strategy for controlling the growth by inhibiting EAG1 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22276743     DOI: 10.1042/CBI20100918

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  11 in total

Review 1.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

Review 2.  Delivery of oligonucleotides with lipid nanoparticles.

Authors:  Yuhua Wang; Lei Miao; Andrew Satterlee; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2015-02-27       Impact factor: 15.470

3.  All-Atom MD Predicts Magnesium-Induced Hairpin in Chemically Perturbed RNA Analog of F10 Therapeutic.

Authors:  Ryan L Melvin; William H Gmeiner; Freddie R Salsbury
Journal:  J Phys Chem B       Date:  2017-08-10       Impact factor: 2.991

4.  miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway.

Authors:  Zhiyong Yan; Shusheng Che; Jianpeng Wang; Yingbing Jiao; Chao Wang; Qinghai Meng
Journal:  Tumour Biol       Date:  2015-02-12

5.  Overexpression of microRNA-155 predicts poor prognosis in glioma patients.

Authors:  Jun Sun; Huachao Shi; Niansheng Lai; Keman Liao; Shuai Zhang; Xiaojie Lu
Journal:  Med Oncol       Date:  2014-03-13       Impact factor: 3.064

Review 6.  Epidermal growth factor receptor as a therapeutic target in glioblastoma.

Authors:  B Kalman; E Szep; F Garzuly; D E Post
Journal:  Neuromolecular Med       Date:  2013-04-11       Impact factor: 3.843

Review 7.  MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.

Authors:  Michael Henriksen; Kasper Bendix Johnsen; Hjalte Holm Andersen; Linda Pilgaard; Meg Duroux
Journal:  Mol Neurobiol       Date:  2014-03-12       Impact factor: 5.590

8.  Prognostic relevance of miRNA-155 methylation in anaplastic glioma.

Authors:  Maximilian Georg Schliesser; Rainer Claus; Thomas Hielscher; Christiane Grimm; Dieter Weichenhan; Jonas Blaes; Benedikt Wiestler; Peter Hau; Johannes Schramm; Felix Sahm; Elisa K Weiß; Markus Weiler; Constance Baer; Friederike Schmidt-Graf; Gabriele Schackert; Manfred Westphal; Anne Hertenstein; Patrick Roth; Norbert Galldiks; Christian Hartmann; Torsten Pietsch; Joerg Felsberg; Guido Reifenberger; Michael Christoph Sabel; Frank Winkler; Andreas von Deimling; Christoph Meisner; Peter Vajkoczy; Michael Platten; Michael Weller; Christoph Plass; Wolfgang Wick
Journal:  Oncotarget       Date:  2016-12-13

9.  Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.

Authors:  Mohammad Norouzi; Vinith Yathindranath; James A Thliveris; Brian M Kopec; Teruna J Siahaan; Donald W Miller
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.